ROYALTY PHARMA PLC news, videos and press releases - Page 2
For more news please use our advanced search feature.
ROYALTY PHARMA PLC - More news...
ROYALTY PHARMA PLC - More news...
- Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
- Royalty Pharma Declares Second Quarter 2024 Dividend
- Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
- Royalty Pharma Reports Q4 and Full Year 2023 Results
- Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
- Royalty Pharma Announces Dividend Increase
- Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
- Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
- Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
- Royalty Pharma Reports Third Quarter 2023 Results
- Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi
- Royalty Pharma Declares Fourth Quarter 2023 Dividend
- Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
- Royalty Pharma Appoints Eric Schneider as Chief Technology Officer
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
- Royalty Pharma to Present at Upcoming Investor Conferences
- Royalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (Nadofaragene Firadenovec-Vncg)
- Royalty Pharma Reports Second Quarter 2023 Results
- Royalty Pharma to Announce Second Quarter 2023 Financial Results on August 8, 2023
- Royalty Pharma Declares Third Quarter 2023 Dividend
- Royalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
- Royalty Pharma Reports First Quarter 2023 Results
- Royalty Pharma To Present At The BofA Securities 2023 Health Care Conference
- Royalty Pharma Declares Second Quarter 2023 Dividend
- Royalty Pharma to Announce First Quarter 2023 Financial Results on May 9, 2023
- Royalty Pharma Announces $1.0 Billion Share Repurchase Program
- Royalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 Million
- Royalty Pharma Raises Full Year 2023 Guidance
- Royalty Pharma Appoints Ashwin Pai as Executive Vice President, Investments
- Royalty Pharma Reports Q4 and Full Year 2022 Results
